Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Balser

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Sh'Ma : a Journal of Jewish Responsibility|November 12, 2003
Access to health care is a human rightRuth B Balser
Nurse Educator|May 1, 1995
Quality post conferencesP Winans-Orr, F Dunham, B Balser
Journal of Visualized Experiments : Jove|July 27, 2017
A Lipid Extraction and Analysis Method for Characterizing Soil Microbes in Experiments with Many SamplesLawrence G Oates, Harry W Read, Jessica L M Gutknecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphomaS Horwitz, B Coiffier, F Foss, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Sh'Ma : a Journal of Jewish Responsibility|November 12, 2003
Access to health care is a human rightRuth B Balser
Nurse Educator|May 1, 1995
Quality post conferencesP Winans-Orr, F Dunham, B Balser
Journal of Visualized Experiments : Jove|July 27, 2017
A Lipid Extraction and Analysis Method for Characterizing Soil Microbes in Experiments with Many SamplesLawrence G Oates, Harry W Read, Jessica L M Gutknecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphomaS Horwitz, B Coiffier, F Foss, et al.
Pageof 1